Cibc Asset Management Inc Vir Biotechnology, Inc. Transaction History

Cibc Asset Management Inc

  • $25.9 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 06, 2022
SELL
$21.19 - $40.01 $110,315 - $208,292
-5,206 Closed
0 $0
Q4 2021

Feb 08, 2022
SELL
$30.97 - $54.03 $216 - $378
-7 Reduced 0.13%
5,206 $218,000
Q3 2021

Nov 09, 2021
BUY
$34.9 - $54.54 $17,938 - $28,033
514 Added 10.94%
5,213 $227,000
Q1 2021

May 14, 2021
BUY
$26.34 - $83.07 $123,771 - $390,345
4,699 New
4,699 $241,000

Others Institutions Holding VIR

# of Institutions
233
Shares Held
87.6M
Call Options Held
231K
Put Options Held
132K
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $999M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email